Download Files:
BAY 2666605
SKU
HY-145924-10 mg
Category Reference compound
Tags Cancer, Metabolic Enzyme/Protease, Phosphodiesterase (PDE)
$300 – $2,700
Products Details
Product Description
– BAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 is a PDE3A-SLFN12 complex inducer (WO2019025562A1; example 135)[1].
Web ID
– HY-145924
Storage Temperature
– -20°C, 3 years (Powder)
Shipping
– Blue Ice
Applications
– Cancer-programmed cell death
Molecular Formula
– C17H12F4N2O2
References
– [1]Manuel ELLERMANN, et al. Dihydrooxadiazinones. WO2019025562A1.
CAS Number
– 2275774-60-0
Molecular Weight
– 352.28
Compound Purity
– 99.64
SMILES
– FC(F)(C1=C(C2=CC=C(C=C2)F)C=CC(C([C@@H](O3)C)=NNC3=O)=C1)F
Clinical Information
– Phase 1
Research Area
– Cancer
Solubility
– DMSO : 250 mg/mL (ultrasonic)
Target
– Phosphodiesterase (PDE)
Isoform
– PDE3
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.